Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Onyx Biotec Ltd

ONYX.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.46

▲ +2.21%

Market Cap $8.34M · Vol 30.00K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$8.34M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

38.70

Momentum

Beta

N/A

vs Market

52W High

$0.53

20.72% below

52W Low

$0.25

81.71% above

Volume

30.00K

Avg 45.47K

P/B

1.11

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Onyx Biotec Ltd (ONYX.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ONYX.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.26%

+18.76%

+47.65%

+27.35%

YTD

+7.84%

-9.47%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$7.43M
Net Income	$-22,941.00
Revenue Growth (YoY)	+9.69%
Gross Margin	21.25%
Operating Margin	0.50%
Net Profit Margin	-0.31%
ROE	N/A
ROA · ROIC	-0.45% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.87
P/B	1.11
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	18.13M

Technical Indicators

50-Day SMA	$0.43
200-Day SMA	$0.38
RSI (14)	38.70
Beta	N/A
52-Week High	$0.53
52-Week Low	$0.25

Volume Today	30.00K
Avg Daily Volume (30D)	45.47K
Relative Volume	0.66x
Volatility (10D)	47.36
Volatility (30D)	55.20
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.46

Mean Target N/A

52W Low$0.25 52W High$0.53

Current

Target

$0.25 $0.53

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG00KHRTFY5

ISININE0WVU01018

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.67% JNJ Johnson & Johnson +1.04% ABBV Abbvie Inc -0.17% NVS Novartis AG -0.53% NOVN.S Novartis AG -0.52%

Company Profile

Onyx Biotec Ltd. is a pharmaceutical company engaged in the manufacture, sale, and distribution of generic and proprietary pharmaceutical products. It develops, manufactures and distributes generic and branded pharmaceutical products in various forms, like water for injection (WFI), dry powder injections, and dry powder syrup. WFI is a sterile preparation of water, which is supplied only in single-dose containers, indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection. Its dry powder injections include Ceftriaxone and Sulbactam for Injection, Cefazoline Sodium for Injection, and Cefepime and Tazobactam for Injection, among others. Its dry powder syrups include Cefpodoxime Proxetil, Cefuroxime Axetil, and others. Its core business is focused on providing end-to-end product development and manufacturing solutions to its clients. Its services also include preparation and filing of regulatory dossiers in the Indian and global markets.